Status:
COMPLETED
Place of Intrathecal Analgesia to Improve the Quality of Life of Painful Cancer Patients
Lead Sponsor:
Institut Cancerologie de l'Ouest
Conditions:
Injections, Spinal
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The intrathecal analgesia is a recommended technic to treat persistent pain in cancer patient but little used, whose the technical conditions require hospital multidisciplinary expertise and coordinat...
Detailed Description
The referent algologist informs the patient of the retained offer in the pain multidisciplinary consultation meeting. Following the consultation, the investigator sees the patient to explain the study...
Eligibility Criteria
Inclusion
- Patient is more than 18 years old with pain linked to the evolution of locoregional or distanced cancer justifying an analgesic treatment administrated by an intrathecal pathway with an implantable pump.
- Patient is able to answer to the questions during the semi-directed interview
- Patient has valid health insurance
- Having given written informed consent prior to any procedure related to the study
Exclusion
- Patient under 18 years-old.
- Patient under guardianship or protection of vulnerable adults
Key Trial Info
Start Date :
February 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2022
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT04388449
Start Date
February 20 2020
End Date
March 1 2022
Last Update
December 28 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut de Cancerologie de l'Ouest
Angers, France, 49055
2
INSERM U987 CHU A Paré - Institut Curie
Boulogne-Billancourt, France, 92100
3
Hopital Foch
Suresnes, France, 92150